Brief: Lyell Immunopharma Q1 Net Income USD -52.195 Million
13/05/2025 21:05
May 13 (Reuters) - Lyell Immunopharma Q1 revenue USD 7 thousand. Q1 operating expenses USD 57.374 million Q1 adjusted net income USD -46.296 million Q1 operating income USD -57.367 million
Recent news on Lyell Immunopharma
See all newsBrief: Lyell Immunopharma Says Additional Clinical Data And End-Of-Phase 1 FDA Meeting Expected In 2027
Lyell Immunopharma, Inc. reports results for the quarter ended June 30 - Earnings Summary
Lyell Immunopharma, Inc. expected to post a loss of $2.08 a share - Earnings Preview
Brief: Lyell Immunopharma Q2 Operating Expenses USD 47.341 Million
Brief: Lyell Immunopharma Shows Updated Safety Data For Ronde-Cel In Patients With Large B-Cell Lymphoma